Leanne Woods-Burnham, PhD Assistant Professor, Department of Physiology Morehouse School of Medicine Dr. Leanne Woods-Burnham is an assistant professor in the Department of Physiology at Morehouse School of Medicine in Atlanta, GA. Her team focuses on prostate cancer health disparities using a translational approach. Dr. Burnham obtained a B.S. in biology from The University of Akron, and a Ph.D. in physiology from Loma Linda University School of Medicine. Her research evaluates ancestry-associated HER2 expression as it relates to worse clinical variables and survival outcomes for Black men with prostate cancer. She is currently funded by the Department of Defense Prostate Cancer Research Program, Prostate Cancer Foundation, the Georgia CTSA KL2 Scholars Program and Pilot Award Program, and an NIH/NIMHD Research Centers for Minority Institutions U54 award. In addition to bench and preclinical studies, Dr. Burnham has fostered several multidisciplinary collaborations with clinicians and pharma to conduct translational race-stratified research studies and clinical trials. She co-directs the Prostate Cancer Precision Prevention Program (PCP3) at Morehouse School of Medicine which leverages community partnerships to provide health education and free prostate-specific antigen (PSA) tests to at-risk men in the greater Atlanta area and rural Georgia. Dr. Burnham has been recognized by Cell’s #FacesofCell Twitter campaign to increase visibility of talented Black scientists, as well as The Cancer Health 25: Black Lives Matter, as a “remarkable individual breaking down racial barriers to better cancer care.”
Dr. Leanne Woods-Burnham is an assistant professor in the Department of Physiology at Morehouse School of Medicine in Atlanta, GA. Her team focuses on prostate cancer health disparities using a translational approach. Dr. Burnham obtained a B.S. in biology from The University of Akron, and a Ph.D. in physiology from Loma Linda University School of Medicine. Her research evaluates ancestry-associated HER2 expression as it relates to worse clinical variables and survival outcomes for Black men with prostate cancer. She is currently funded by the Department of Defense Prostate Cancer Research Program, Prostate Cancer Foundation, the Georgia CTSA KL2 Scholars Program and Pilot Award Program, and an NIH/NIMHD Research Centers for Minority Institutions U54 award. In addition to bench and preclinical studies, Dr. Burnham has fostered several multidisciplinary collaborations with clinicians and pharma to conduct translational race-stratified research studies and clinical trials. She co-directs the Prostate Cancer Precision Prevention Program (PCP3) at Morehouse School of Medicine which leverages community partnerships to provide health education and free prostate-specific antigen (PSA) tests to at-risk men in the greater Atlanta area and rural Georgia. Dr. Burnham has been recognized by Cell’s #FacesofCell Twitter campaign to increase visibility of talented Black scientists, as well as The Cancer Health 25: Black Lives Matter, as a “remarkable individual breaking down racial barriers to better cancer care.”
